Startups channel feed – Endpoints News

Startups channel feed

Third Rock, GV back Broad spinout Celsius in bid to develop precision meds for autoimmune disease

7 years ago

CRISPR trailblazers Zhang, Liu and Joung join forces to launch Beam with $87M and cutting-edge gene-editing tech

7 years ago

Eight years after Eli Lilly dumped it, an upstart biotech has nabbed teplizumab and filed a $56M IPO to back a PhIII comeback

8 years ago

Ex-Receptos CTO co-founds SD startup Escient, launching with $40M Series A

8 years ago

Third Rock sinks $59M into Casma's 'recycling' tech, with neuro on the mind

8 years ago

Chinese investors back Refuge Bio’s $25M B round as it steers gene engineering tech to an IND

8 years ago

Out to ‘rethink the drug design process,’ AI star Daphne Koller is creating a new machine learning venture at insitro with some heavyweight backers

8 years ago

Omega Funds leads $35M Series A to fuel Attenua's cough program, set for proof-of-concept this year

8 years ago

IL-2 without the toxic side effects? Orbimed backs the idea in Synthorx' $63M round

8 years ago

CRISPR legend Jennifer Doudna helps some recent college grads launch a diagnostics upstart

8 years ago

After decades in the big leagues, Martin Mackay is going small — and he's delighted

8 years ago

Protein degradation 2.0? Third Rock sinks $56M into Cedilla's unusual approach

8 years ago

VC believers back a $41M game plan for Enterprise Therapeutics' new group of respiratory drugs

8 years ago

Vivek Ramaswamy is diving into RNA, launching a new biotech with Arbutus and a team of vets

8 years ago

Harvard big-shots Kevin Eggan and Clifford Woolf launch ALS startup with exclusive Q-State tech

8 years ago

Roche grabs a remyelination MS drug from Versant as the research team spins out into a $25M regenerative med startup

8 years ago

Eli Lilly hands transpacific biotech upstart Terns pieces to an experimental NASH puzzle

8 years ago

Arie Belldegrun raises $300M, grabs Pfizer’s allogeneic CAR-T portfolio and launches a groundbreaking drive to commercialization

8 years ago

Backed by giants, antibiotics upstart Macrolide gets $20M and an ex-Novartis exec as CEO

8 years ago

Chinese oncology startup Adagene closes $50M Series C led by Sequoia Capital

8 years ago

With major funding from Novartis, Surface Oncology launches a CD47 trial amid a swarm of rivals and files for $75M IPO

8 years ago

Backed in part by Roche, Denmark's NMD gets $47M to run orphan neuromuscular disease trials

8 years ago

Third Rock debuts immunometabolism startup Rheos with $60M launch round

8 years ago

CRISPR pioneer Feng Zhang co-founds a 'limitless' biotech upstart with big plans for speeding new drug development

8 years ago

First page Previous page 63 64 656667 68 69 Next page Last page